A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2002
10/17/2002	US20020150628 Microbiocides; viricides; anticancer agents
10/17/2002	US20020150624 Mixture of drug, aminoacrylate polymer and acid
10/17/2002	US20020150620 Oral itraconazole formulations and methods of making the same
10/17/2002	US20020150595 Antigenic preparations and the isolation of such preparations
10/17/2002	US20020150591 Amplification nucleic acids
10/17/2002	US20020150587 Immunological polypeptides; vaccine against gramnegative bacteria
10/17/2002	US20020150570 Anti-CCR2 antibodies and methods of use therefor
10/17/2002	US20020150565 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
10/17/2002	US20020150554 Chicken interleukin-15 and uses thereof
10/17/2002	US20020150552 Compositions comprising mixtures of therapeutic proteins and methods of producing the same
10/17/2002	US20020150551 Protease surface treatment
10/17/2002	US20020150549 Sustained release
10/17/2002	US20020150541 Mixture of human interferons; viricides; anticancer agents; antiinflammatory agents;
10/17/2002	DE10201458A1 New proteins involved in isoprenoid biosynthesis, useful in screening for inhibitors, also new intermediates, potential therapeutic agents, nucleic acids and antibodies
10/17/2002	DE10118550A1 New 3-ethanoylamino-3-phenyl-propionic acid derivatives, are integrin agonists or antagonists useful e.g. for treating angiogenic, cardiovascular, inflammatory, osteolytic or tumor diseases or infections
10/17/2002	DE10117728A1 Pharmazeutische Formulierungen für Xanthogenate Pharmaceutical formulations for xanthates
10/17/2002	DE10117184A1 Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen Substituted imidazol [1,2-a] pyridin-3-yl-amide, and amine compounds of
10/17/2002	CA2810326A1 Vaccine composition
10/17/2002	CA2762966A1 Hsa-free formulations of interferon-beta
10/17/2002	CA2727715A1 Vaccine composition
10/17/2002	CA2446462A1 Chimeric vaccines
10/17/2002	CA2443813A1 Method for identification of proteins from intracellular bacteria
10/17/2002	CA2443323A1 Nucleic acid vaccines for prevention of flavivirus infection
10/17/2002	CA2443085A1 Somatostatin agonists
10/17/2002	CA2442996A1 Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments
10/17/2002	CA2442986A1 Use of substituted imidazo[1,2-a]-pyridine-3-yl-amide and imidazo[1,2-a]-pyridine-3-yl-amine compounds as medicaments
10/17/2002	CA2442739A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/17/2002	CA2442386A1 Epitope sequences
10/17/2002	CA2442092A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
10/17/2002	CA2441499A1 Method for producing a vaccine
10/17/2002	CA2441442A1 Conjugate of hydroxyalkyl starch and an active agent
10/17/2002	CA2440724A1 Pyrazolopyrimidines as therapeutic agents
10/17/2002	CA2439503A1 Recombination super compound interferon used as hepatitis b surface antigen and e antigen inhibitor
10/17/2002	CA2439111A1 Mucosal boosting following parenteral priming
10/17/2002	CA2434693A1 Ionene polymers and their use as antimicrobial agents
10/16/2002	EP1248858A1 Antisense modulation of caspase 8 expression
10/16/2002	EP1248849A1 Obg3 globular head and uses thereof for decreasing body mass
10/16/2002	EP1248847A1 Irak-4: compositions and methods of use
10/16/2002	EP1248842A1 2871 receptor, a g-protein coupled receptor and methods of use thereof
10/16/2002	EP1248836A2 Hybrid cells obtainable from antigen presenting cells
10/16/2002	EP1248830A1 Antimicrobial compositions
10/16/2002	EP1248813A2 Antisense antibacterial cell division composition and method
10/16/2002	EP1248801A1 Human polynucleotides, polypeptides, and antibodies
10/16/2002	EP1248799A2 Chemically modified hiv envelope glycoprotein
10/16/2002	EP1248787A2 Novel subtituted pyrazolo[4, 3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them
10/16/2002	EP1248785A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
10/16/2002	EP1248783A1 Arylsulfonic acid salts of pyrimidine-based antiviral agents
10/16/2002	EP1248782A1 Anticancer compound and enantiomer separation method useful for synthesizing said compound
10/16/2002	EP1248781A1 Pyrazole cyclic amp-specific pde inhibitors
10/16/2002	EP1248777A2 Tricyclic compounds with antiviral activity
10/16/2002	EP1248771A1 Method for preparing hydroxypicolinic acid derivatives
10/16/2002	EP1248654A2 Intra-tumoral administration of il-12 encoding nucleic acid molecules
10/16/2002	EP1248650A2 Improved dna vaccines for production-type animals
10/16/2002	EP1248648A2 Vaccination against canine herpesvirus infection and vaccines
10/16/2002	EP1248647A1 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
10/16/2002	EP1248645A1 Novel chimeric proteins and methods for using the same
10/16/2002	EP1248644A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this
10/16/2002	EP1248629A1 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
10/16/2002	EP1248624A1 3,4-DIHYDRO-(1H)-QUINAZOLIN-2-ONES AND THEIR USE AS CSBP/p38 KINASE INHIBITORS
10/16/2002	EP1248603A2 Use of particular compounds for prophylaxis and treatment of hepatitis c
10/16/2002	EP1248600A1 Improved pharmaceutical formulations
10/16/2002	EP1248516A2 38 human secreted proteins
10/16/2002	EP1159279B1 4-oxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents
10/16/2002	EP1037652B1 Pharmaceutical compositions based on dalfopristin and quinupristin and preparation
10/16/2002	EP0991653B1 Novel compounds
10/16/2002	EP0975632B1 Alkaloid halide salts of swainsonine and methods of use
10/16/2002	EP0944385B1 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating helicobacter pylori infections and the gastroduodenal diseases associated therewith
10/16/2002	EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/16/2002	EP0910354B1 Antioxidant compounds
10/16/2002	EP0877605B1 Solid instant-release forms of administration and process for producing the same
10/16/2002	EP0831826B1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
10/16/2002	EP0813542B1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/16/2002	EP0812193B1 Pharmaceutical compositions containing a benzydamine or its salt and an antimicrobial agent
10/16/2002	EP0808168B1 Pharmaceutical composition for the treatment of herpes
10/16/2002	EP0750669B1 MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM
10/16/2002	EP0670847B1 Subtilin variant of enhanced stability and activity
10/16/2002	EP0637976B2 Medicament for disinfection of the oral cavity
10/16/2002	EP0619742B1 Transfection of lung via aerosolized transgene delivery
10/16/2002	EP0538297B9 Antiviral tetrahydroimidazo 1,4]benzodiazepin-2-(thio)ones
10/16/2002	CN1375004A Methods and compsotions for inhibiting the function of polynucleotide sequences
10/16/2002	CN1374966A 嘌呤衍生物 Purine derivatives
10/16/2002	CN1374960A Novel integrain receptor antagonists
10/16/2002	CN1374959A Piperidine quinolyl propyl derivatives, preparation method and compositions containing same
10/16/2002	CN1374874A Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions
10/16/2002	CN1374873A Anionic amino acid based surfactants to enhance antimicrobial effectiveness of topical pharmaceutical compositions
10/16/2002	CN1374868A Pharmaceutical composition that contains eucalyptus and orange oil
10/16/2002	CN1374859A 药物粉剂 Drug powder
10/16/2002	CN1374325A Giant-web bombinator antimicrobial peptide and its prepn and gene
10/16/2002	CN1374316A Macrocyclic target specific antisense nucleic acid compound
10/16/2002	CN1374314A Amorphous Adefuweizhi ester amorphous solid matter and its prepn
10/16/2002	CN1374309A Application of cinidium general coumarin as psoriasis treating medicine
10/16/2002	CN1374131A AIDS treating medicine Boke capsule and its prepn
10/16/2002	CN1374126A Medicine for clearing away heat and toxic material and its prepn
10/16/2002	CN1374124A Chinese herbal medicine composition for treating pyloric spirobacterium infected gastropathy and its production process
10/16/2002	CN1374114A New prepn process of Lideri as one traditional Mongoliam medicine
10/16/2002	CN1374109A Medicine for treating drug-fast tuberculosis
10/16/2002	CN1374106A Chinese medicine prepn for treating hepatitis B and its prepn process
10/16/2002	CN1374092A Tuber culosis treating Chinese medicine
10/16/2002	CN1374087A Specific compound cold treating medicine
10/16/2002	CN1374083A Cold resisting compound medicinal composition

1 ... 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 ... 1798